22 Cherry Hill Drive
Danvers,  MA  01923

United States
  • Booth: 2923


Abiomed (NASDAQ: ABMD) is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with the pumping function of the heart.


  • Impella CP® with SmartAssist®
    Minimally invasive heart pump with intelligent technology to improve patient outcomes with peak flows up to 4.3 L/min....

  • The Impella CP with SmartAssist heart pump is designated as safe and effective by the FDA for use during high-risk PCI procedures and for patients in cardiogenic shock. It is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery.

  • Impella 5.5® with SmartAssist®
    A heart pump designed for surgeons with forward flow and intelligent patient management....

  • Impella 5.5 with SmartAssist delivers full cardiac support with maximum unloading, allowing the heart to rest and recover.  It is a microaxial, surgically implanted heart pump that unloads the left ventricle, reduces ventricular work, and provides the circulatory support necessary to allow recovery and early assessment of residual myocardial function. It is designed for long-duration support and enables ambulation to optimize recovery while using real-time SmartAssist intelligence.

  • Impella RP® with SmartAssist®
    The only percutaneous, single vascular access pump approved for right heart support....

  • The Impella RP with SmartAssist heart pump is the world’s first and only percutaneous FDA-approved device for right heart support. This technology pumps blood from the inferior vena cava to the pulmonary artery. The pump is inserted with venous access and advanced over a wire into the pulmonary artery using standard catheterization techniques.

    • Provides circulatory assistance for up to 14 days in certain patients with a body surface area ≥ 1.5 m2
    • Delivers flow of greater than 4.0 L/min of blood
    • Enables biventricular support when the left side is already supported with a left-sided Impella®

 Additional Info

ACC.22 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies, Interventional and Structural Cardiology